RETRACTED ARTICLE: Effect of myo-inositol and melatonin versus myo-inositol, in a randomized controlled trial, for improving in vitro fertilization of patients with polycystic ovarian syndrome
The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
Polycystic ovarian syndrome (PCOS) induces anovulation in women of reproductive age, and is one of the pathological factors involved in the failure of in vitro fertilization (IVF). Indeed, PCOS women are characterized by poor quality oocytes. Therefore, a treatment for enhancing oocyte quality becomes crucial for these patients. Myo-Inositol and melatonin proved to be efficient predictors for positive IVF outcomes, correlating with high oocyte quality. We tested the synergistic effect of myo-inositol and melatonin in IVF protocols with PCOS patients in a randomized, controlled, double-blind trial. Five-hundred twenty-six PCOS women were divided into three groups: Controls (only folic acid: 400 mcg), Group A (Inofolic® plus, a daily dose of myo-inositol: 4000 mg, folic acid: 400 mcg, and melatonin: 3 mg), and Group B (Inofolic®, a daily dose of myo-inositol: 4000 mg, and folic acid: 400 mcg). The main outcome measures were oocyte and embryo quality, clinical pregnancy and implantation rates. The treatment lasted from the first day of the cycle until 14 days after embryo transfer. Myo-inositol and melatonin have shown to enhance, synergistically, oocyte and embryo quality. In consideration of the beneficial effect observed in our trial and on the bases of previous studies, we decided to integrate routinely MI and M supplementation in the IVF protocols. The same treatment should be taken carefully in consideration in all procedures of this kind.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Ten studies specifically enrolled women with PCOS who also had infertility (25, 27, 40, 46-51, 55, 56).”
From Inositol for Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis to Inform the 2023 Update of the International Evidence-based PCOS Guidelines (2024) · cites this paper as [47]
In the citing paper
“Ten used FA at doses ranging from 200 to 400 mcg daily (25, 27, 29, 31, 34, 37, 46-49).”
From Inositol for Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis to Inform the 2023 Update of the International Evidence-based PCOS Guidelines (2024) · cites this paper as [47]
In the citing paper
“One study did not clearly define treatment duration (48), and 1 study only provided inositol during IVF stimulation (47).”
From Inositol for Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis to Inform the 2023 Update of the International Evidence-based PCOS Guidelines (2024) · cites this paper as [47]
In the citing paper
“There were 8 studies (25, 27, 31, 34, 46-49) that compared MI + FA to FA alone.”
From Inositol for Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis to Inform the 2023 Update of the International Evidence-based PCOS Guidelines (2024) · cites this paper as [47]
In the citing paper
“The dose of MI used was 4 g daily in 6 of the studies (25, 31, 46-49) with 200 to 400 mcg of FA.”
From Inositol for Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis to Inform the 2023 Update of the International Evidence-based PCOS Guidelines (2024) · cites this paper as [47]
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
4 retracted
Papaleo, E., Unfer, V., Baillargeon, J.-P., Fusi, F., Occhi, F., & De Santis, L. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.01.088 · Cited by 197 · cited 3×
“Due to the beneficial effect exerted by MI in Assisted Reproductive Technology procedure [8,17], we adopted routinely MI treatment in our stimulation protocols.”
Retracted- Retracted
RETRACTED: Contribution of myo-inositol and melatonin to human reproduction
Carlomagno, G., Nordio, M., Chiu, T. T. Y., & Unfer, V. (2011) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2011.07.038 · Cited by 92
Self-citationRetractedSelman, H. A., Pacchiarotti, A., Rinaldi, L., Crescenzi, F., Lanzilotti, G., Lofino, S., & El-Danasouri, I. (2013) · PubMed · Cited by 16
Self-citationRetractedDevelopment of Follicles in the Mammalian Ovary
Hirshfield, A. N. (1991) · International Review of Cytology · doi:10.1016/s0074-7696(08)61524-7 · Cited by 1,277 · cited 1×
“Previous works [26–28] have clearly demonstrated that both the M receptor isoforms [29,30], MT 1 -”
Reppert, S. M., Weaver, D. R., & Ebisawa, T. (1994) · Neuron · doi:10.1016/0896-6273(94)90055-8 · Cited by 1,096 · cited 1×
“Previous works [26–28] have clearly demonstrated that both the M receptor isoforms [29,30], MT 1 -”
Hormonal Regulation of the Differentiation of Cultured Ovarian Granulosa Cells*
HSUEH, A. J. W., ADASHI, E. Y., JONES, P. B. C., & WELSH, T. H. (1984) · Endocrine Reviews · doi:10.1210/edrv-5-1-76 · Cited by 1,011 · cited 1×
“The effects of gonadotropins on follicular growth, ovulation, and luteinization, are associated with differences in FSH and LH receptor concentrations [44–46].”
Melatonin and the Mammalian Pineal Gland
Arendt, J. (1994) · Cited by 788
Tamura, H., Takasaki, A., Miwa, I., Taniguchi, K., Maekawa, R., Asada, H., Taketani, T., Matsuoka, A., Yamagata, Y., Shimamura, K., et al. (2008) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2007.00524.x · Cited by 693 · cited 1×
“Similarly, supplementation of MI or M has been proven to have an effect on oocyte and embryo quality [8,17,40,41].”
Melatonin: A Multitasking Molecule
Reiter, R. J., Tan, D.-X., & Fuentes-Broto, L. (2010) · Progress in Brain Research · doi:10.1016/s0079-6123(08)81008-4 · Cited by 642 · cited 1×
“M receptors have been identified in hypothalamic neurons that govern the release of pituitary gonadotropins, in the anterior pituitary, and in both female and male gonads, as well as in other reproductive organs [25].”
Cited by
Lateef, O. M., & Akintubosun, M. O. (2020) · Journal of Circadian Rhythms · doi:10.5334/jcr.190 · Cited by 203
Is Melatonin the Cornucopia of the 21st Century?
Ferlazzo, N., Andolina, G., Cannata, A., Costanzo, M. G., Rizzo, V., Currò, M., Ientile, R., & Caccamo, D. (2020) · Antioxidants · doi:10.3390/antiox9111088 · Cited by 189
Antioxidants for female subfertility
Showell, M. G., Brown, J., Clarke, J., & Hart, R. J. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007807.pub2 · Cited by 184
Minich, D. M., Henning, M., Darley, C., Fahoum, M., Schuler, C. B., & Frame, J. (2022) · Nutrients · doi:10.3390/nu14193934 · Cited by 176
Hardy, M. L. M., Day, M. L., & Morris, M. B. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph182111374 · Cited by 146
Metadata
- Authors
- Pacchiarotti, A., Carlomagno, G., Antonini, G., & Pacchiarotti, A.
- Affiliations
- Sapienza University of Rome (IT)
- Farmares SRL
- Corresponding author
- Pacchiarotti, Arianna
- ORCID
- Antonini, Gabriele
- Venue
- Gynecological Endocrinology
- Publisher
- Informa UK Limited
- Published
- 2015-10-28
- Volume
- 32
- Issue
- 1
- Pages
- 69-73
- ISSN
- 0951-3590 (ISSN-L)
- 1473-0766
- OpenAlex
- W1844254983
- Cited by
- 111
- References
- 46
- Citations by year
- 2026: 6 · 2025: 16 · 2024: 18 · 2023: 8 · 2022: 9 · 2021: 15 · 2020: 8 · 2019: 7 · 2018: 8 · 2017: 8 · 2016: 7
- FWCI
- 8.74
- Type
- journal article
- Language
- en
- Status
- Retracted
- Open access
- closed
- Locations
- Gynecological Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Reproductive Medicine › Reproductive Biology and Fertility
- Health Sciences › Medicine › Reproductive Medicine › Reproductive Health and Technologies
- Keywords
- myo-inositol, melatonin, polycystic ovary syndrome, in vitro fertilization, oocyte quality, embryo quality, clinical pregnancy rate, implantation rate, folic acid supplementation, synergistic supplementation, retracted article
- MeSH terms
- Adult, Antioxidants, Double-Blind Method, Drug Therapy, Combination, Embryo Transfer, Female, Fertilization in Vitro, Folic Acid, Humans, Infertility, Female, Inositol, Melatonin, Oocytes, Polycystic Ovary Syndrome, Pregnancy, Vitamin B Complex, Treatment Outcome, Pregnancy Rate, Dietary Supplements
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: RETRACTED ARTICLE: Effect of myo-inositol and melatonin versus myo-inositol, in a randomized controlled trial, for improving in vitro fertilization of patients with polycystic ovarian syndrome. https://app.cochat.ai/papers/10.3109/09513590.2015.1101444
- The paper
- Pacchiarotti, A., Carlomagno, G., Antonini, G., & Pacchiarotti, A. (2016). RETRACTED ARTICLE: Effect of myo-inositol and melatonin versus myo-inositol, in a randomized controlled trial, for improving in vitro fertilization of patients with polycystic ovarian syndrome. Gynecological Endocrinology. https://doi.org/10.3109/09513590.2015.1101444
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.